Lundbeck
HLUN-B.CO
$4.72
Share price
-0.55%
Change (1 day)
-9.92%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Lundbeck (HLUN-B.CO) - Net assets
Net assets on the balance sheet as of December 2023 : $3.26 B
According to Lundbeck
's latest financial reports the company has $3.26 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Lundbeck - Net assets on balance sheet (from 2009 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $3.26 B | 9.11% |
| 2022-12-31 | $2.99 B | 7.52% |
| 2021-12-31 | $2.78 B | -0.81% |
| 2020-12-31 | $2.80 B | 11.5% |
| 2019-12-31 | $2.51 B | 15.24% |
| 2018-12-31 | $2.18 B | 11.19% |
| 2017-12-31 | $1.96 B | 43.07% |
| 2016-12-31 | $1.37 B | 6.61% |
| 2015-12-31 | $1.28 B | -41.72% |
| 2014-12-31 | $2.20 B | -11.49% |
| 2013-12-31 | $2.49 B | 6.65% |
| 2012-12-31 | $2.34 B | 5.15% |
| 2011-12-31 | $2.22 B | 12.13% |
| 2010-12-31 | $1.98 B | 17.05% |
| 2009-12-31 | $1.69 B | 20.23% |
| 2008-12-31 | $1.41 B | 0.31% |
| 2007-12-31 | $1.40 B | 17.22% |
| 2006-12-31 | $1.19 B | 1.12% |
| 2005-12-31 | $1.18 B | -16.88% |
| 2004-12-31 | $1.42 B |